Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/16/17 | Annual report pursuant to Section 13 and 15(d) |
|
 |
110 | |
| 03/15/17 | Current report filing |
|
8 | ||
| 02/16/17 | Current report filing |
|
5 | ||
| 02/15/17 | Current report filing |
|
34 | ||
| 02/06/17 | Annual statement of changes in beneficial ownership of securities |
|
1 | ||
| 02/06/17 | Annual statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/11/17 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
17 | ||
| 01/04/17 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/04/17 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/04/17 | Statement of changes in beneficial ownership of securities |
|
1 |